OP09.05: Minimally invasive management of cervical ectopic pregnancies.

This article discusses the efficacy and safety of minimally invasive approaches in the treatment of cervical ectopic pregnancy (CEP). The study analyzed cases of CEP at a New York City medical center from 2010 to 2023. The primary treatment options included transvaginal ultrasound-guided feticide, transcervical balloon catheter insertion, and systemic methotrexate (MTX). The results showed that both transvaginal ultrasound-guided feticide and transcervical balloon catheter were effective in resolving live CEP without surgical intervention. Systemic MTX was used for non-live CEP cases, with some requiring additional interventions. Overall, the study suggests that minimally invasive management can successfully treat CEP. [Extracted from the article]